收藏切换
Overexpression of SOX-2 Promotes Osimertinib Resistance in EGFR-Mutated Lung Adenocarcinoma Cells: A Preliminary in vitro Study
收藏切换
Yizhi ZHANG, Bei WANG, Yawen WANG, Kejing TANG*
Pharmacy Today | 2026, 36(7) : 505 - 511
Less
收藏切换
Pharmacy Today | 2026, 36(7): 505-511
Overexpression of SOX-2 Promotes Osimertinib Resistance in EGFR-Mutated Lung Adenocarcinoma Cells: A Preliminary in vitro Study
Full
Yizhi ZHANG, Bei WANG, Yawen WANG, Kejing TANG*
Affiliations
  • The Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China
Published: 2026-07-25 doi: 10.12048/j.issn.1674-229X.2026.07.004
Outline
收藏切换
OBJECTIVE

Patients with EGFR-mutated lung adenocarcinoma often develop acquired resistance to targeted drugs such as Osimertinib,leading to poor prognosis. Tumor stem cell properties are an important mechanism for drug resistance,and the role of the stemness gene SOX-2 in Osimertinib resistance remains unclear. This study aimed to investigate the function of SOX-2 in Osimertinib resistance in EGFR-mutated lung adenocarcinoma.

METHODS

This study first analyzed the expression of SOX-2 in lung adenocarcinoma and its correlation with prognosis using the public databases GEPIA,TIMER,and HPA. Additionally,SOX-2 was overexpressed in lung adenocarcinoma cell lines H1975 and PC9,and cellular sensitivity to Osimertinib was assessed using the CCK-8 assay. Sphere-forming capacity was evaluated via 3D Matrigel culture assay.

RESULTS

Overexpression of SOX-2 significantly enhanced the resistance of H1975 and PC9 cells to Osimertinib and enhanced their clonogenic capacity and proliferative ability under three-dimensional culture conditions.

CONCLUSION

High SOX-2 expression promotes Osimertinib resistance in EGFR-mutated lung adenocarcinoma,and this study provides experimental evidence for the prognosis assessment of EGFR-mutated lung adenocarcinoma.

stemness gene  /  SOX-2  /  EGFR-mutated lung adenocarcinoma  /  Osimertinib resistance
张宜之, 王倍, 王雅文, 唐可京. SOX-2过表达促进EGFR突变肺腺癌细胞对奥希替尼的耐药性:1项体外初步研究. 今日药学, 2026 , 36 (7) : 505 -511 . DOI: 10.12048/j.issn.1674-229X.2026.07.004
Yizhi ZHANG, Bei WANG, Yawen WANG, Kejing TANG. Overexpression of SOX-2 Promotes Osimertinib Resistance in EGFR-Mutated Lung Adenocarcinoma Cells: A Preliminary in vitro Study[J]. Pharmacy Today, 2026 , 36 (7) : 505 -511 . DOI: 10.12048/j.issn.1674-229X.2026.07.004
Year 2026 volume 36 Issue 7
65
14
Cite this Article
BibTeX
Article Info
doi: 10.12048/j.issn.1674-229X.2026.07.004
  • Receive Date:2025-11-04
  • Online Date:2026-10-27
  • Published:2026-07-25
Article Data
Affiliations
History
  • Received:2025-11-04
Funding
Affiliations
    The Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China
References
Share
https://castjournals.cast.org.cn/joweb/jryx/EN/10.12048/j.issn.1674-229X.2026.07.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT